Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
There is no evidence that calorie needs change specifically on injection day
Preventing injection site reactions, including bubble formation, requires a systematic approach to injection preparation and site management
The test analyzes 14 peptide-pathway genes including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313
Walgreens Weight Management is currently intended for patients self-paying for weight loss medication
UHCs typical prior authorization requirements for Wegovy and Zepbound include: BMI documentation A documented BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea Comorbidity evidence Clinical records documenting the specific comorbidities that support the medical necessity of treatment Supervised weight management history Evidence of participation in a structured weight management program, which may include diet, exercise, and behavioral counseling, typically for 3 to 6 months prior to the request Prescriber qualifications The prescriber must be a physician, nurse practitioner, or physician assistant with appropriate prescribing authority UHC reviews prior authorizations against specific clinical policy bulletins
US$ 28.73
US$ 20.18
US$ 28.00
